3 ms·
To offer context for others: The bigger deal about this is that KRAS was considered an "undruggable" target. Recent advancements have allowed us to design bio
by gavinray 4mo ago
To offer context for others:
The bigger deal about this is that KRAS was considered an "undruggable" target.
Recent advancements have allowed us to design biologics to do things we previously thought impossible, which broadens the horizons for other treatments in the future.
Baby steps.
- Nippon_anzai 4mo agoWhat's next then?
- SubiculumCode 4mo agoOther cancers, obesity, name it.
- pharaohgeek 4mo agoThe Johns Hopkins Children's' Center is looking at trialing it for rhabdomyosarcoma, a particularly deadly form of cancer that primary targets children. If successful, this would represent a HUGE leap forward in its treatment.